A Phase 1 Study of Healthy Donor CD19-targeted Allogeneic CAR T Cells in Participants with Severe, Refractory Autoimmune Diseases

Status

Recruiting

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2024-517681-41-00

Acronym

IM060-0001

Enrollment

Registered

2025-07-16

Start date

2025-08-29

Completion date

Unknown

Last updated

2025-10-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Idiopathic Inflammatory Myopathy, Rheumatoid Arthritis, Systemic Lupus Erythematosus, Systemic Sclerosis

None listed

Sex/Gender

All

Age

18 Years to No maximum

Czechia, France, Germany, Poland, Romania, Spain

None listed

Source: EU CTIS · Data processed: Feb 4, 2026